Mikhail Lisovsky Selected Research

late gestation lung 2 karyopherin

7/2009

Cell polarity protein Lgl2 is lost or aberrantly localized in gastric dysplasia and adenocarcinoma: an immunohistochemical study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mikhail Lisovsky Research Topics

Disease

9	Neoplasms (Cancer) 03/2021 - 01/2008
6	Adenocarcinoma 06/2022 - 07/2009
4	Esophagitis 01/2021 - 10/2016
3	Gastroesophageal Reflux (GERD) 01/2021 - 12/2016
3	Inflammation (Inflammations) 01/2021 - 01/2019
2	Esophageal Achalasia (Megaesophagus) 01/2021 - 10/2016
2	Esophageal Diseases 12/2020 - 01/2019
2	Esophageal Neoplasms (Esophageal Cancer) 09/2014 - 09/2014
2	Carcinoma (Carcinomatosis) 04/2013 - 08/2007
1	Pathologic Complete Response 06/2022
1	Neoplasm Metastasis (Metastasis) 03/2021
1	Peptic Esophagitis (Reflux Esophagitis) 01/2021
1	End Stage Liver Disease 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Lymphocytosis 01/2021
1	Carcinoid Tumor (Carcinoid) 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2017
1	Neoplasms, Cystic, Mucinous, and Serous 03/2017
1	Autoimmune Pancreatitis 03/2017
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Deglutition Disorders (Dysphagia) 10/2016
1	Crohn Disease (Crohn's Disease) 10/2016
1	Eosinophilic Esophagitis 10/2016
1	Fatigue 02/2016
1	Abdominal Pain (Pain, Abdominal) 02/2016
1	Esophageal Squamous Cell Carcinoma 09/2014
1	Pathologic Constriction (Stenosis) 09/2014
1	Carcinogenesis 09/2014
1	Aneurysm (Aneurysms) 11/2011
1	Barrett Esophagus (Barrett's Esophagus) 09/2011
1	Prolapse 05/2011
1	Polyps 05/2011
1	Melanoma (Melanoma, Malignant) 01/2008
1	Neurofibroma 01/2008
1	Pigmented Nevus (Melanocytic Nevus) 01/2008
1	Fibroma (Fibromatosis) 01/2008
1	Fasciitis (Fascitis) 01/2008
1	Benign Fibrous Histiocytoma (Dermatofibroma) 01/2008
1	Desmoplastic Fibroma 01/2008
1	Dermatofibrosarcoma 01/2008
1	Neurothekeoma 01/2008
1	Malignant Fibrous Histiocytoma 01/2008
1	Solitary Fibrous Tumors 01/2008
1	Myxoma (Myxomas) 01/2008
1	Prostatic Neoplasms (Prostate Cancer) 12/2006

Drug/Important Bio-Agent (IBA)

3	LyeIBA 01/2021 - 10/2016
2	Hematoxylin (Haematoxylon)IBA 01/2021 - 09/2011
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 09/2011
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2014
2	EnzymesIBA 02/2016 - 12/2006
2	Proteins (Proteins, Gene)FDA Link 06/2010 - 07/2009
1	S100 Proteins (S 100 Protein)IBA 03/2021
1	ChromatinIBA 02/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Immunoglobulin G (IgG)IBA 03/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	TransferasesIBA 09/2014
1	SteroidsIBA 09/2014
1	Docetaxel (Taxotere)FDA Link 04/2013
1	Capecitabine (Xeloda)FDA Link 04/2013
1	ParaffinIBA 09/2011
1	Capsules (Microcapsules)IBA 09/2011
1	Reticulin (Reticular Fiber)IBA 09/2011
1	AntralIBA 05/2011
1	late gestation lung 2 karyopherinIBA 07/2009
1	Glycoproteins (Glycoprotein)IBA 01/2008
1	Apolipoproteins D (Apo D)IBA 01/2008
1	HDL LipoproteinsIBA 01/2008
1	Keratin-5 (Keratin 5)IBA 08/2007
1	Racemases and Epimerases (Epimerases and Racemases)IBA 12/2006
1	Coenzyme A (CoA)IBA 12/2006
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2006

Therapy/Procedure

5	Therapeutics 12/2020 - 11/2010
2	Neoadjuvant Therapy 06/2022 - 11/2010
1	Fundoplication 12/2016
1	Radiotherapy 04/2013
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 11/2011
1	Time-to-Treatment 11/2010